THE CANCER TREATMENT AND RESEARCH TRUST CIO

Registered charity 1194608 · accounts filings on the Charity Commission register

Support research in medical oncology.

Objects

THE OBJECTS OF THE CIO ARE THE PROMOTION OF MEDICAL AND SCIENTIFIC RESEARCH INTO THE CAUSES AND TREATMENT OF CANCER AND RELATED DISEASES AND THE DISSEMINATION OF THE USEFUL RESULTS OF SUCH RESEARCH AND FOR THE TREATMENT AND CARE OF PEOPLE SUFFERING FROM CANCER AND RELATED DISEASES.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Hillingdon, London, England (from the postcode on the register)

Latest income
£326k
Latest spending
£284k
Registered
2021
Accounts read
FY2025

Financial health, per its FY2025 accounts

The charity holds unrestricted free reserves of £1,221,038, which significantly exceed the trustees' stated policy target of covering two years of operating costs (£130,000). The trustees consider the charity to be a going concern, citing adequate resources to meet obligations for at least the next 12 months. Total income for the year was £325,771, with total expenditure at £283,831, resulting in a net surplus.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Donations and legacies (92% of income)
“Total income for the year was £325,771 (2024: £502,151), derived primarily from donations and investment income.” — page 14
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: two years of the charity's operating costs, together with the funding required to meet existing research commitments (reserves figure: £1.3m)
“The trustees’ policy is to maintain sufficient reserves to cover two years of the charity's operating costs, together with the funding required to meet existing research commitments.” — page 15
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/12/2025

  • Volunteers: 1
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/12/2024

  • Volunteers: 2
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/12/2023

  • Volunteers: 2

Source: this charity’s annual returns on the Charity Commission register.

Annual return filing dates (Charity Commission record)

Of its last 5 annual returns with a recorded received date, 4 were received after the due date: year ending 31/12/2024 (received 01/07/2026, 243 days after the 31/10/2025 due date); year ending 31/12/2023 (received 25/03/2025, 145 days after the 31/10/2024 due date); year ending 31/12/2022 (received 22/06/2024, 235 days after the 31/10/2023 due date); year ending 31/12/2021 (received 05/09/2023, 309 days after the 31/10/2022 due date).

Due and received dates as recorded in the Commission’s annual-return data; the data does not say whether an extension was agreed. Source: this charity’s annual returns on the Charity Commission register.

Public fundraising profile: JustGiving — Cancer Treatment And Research Trust CIO (matched by registered charity number).

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/12/2024)

Total income
£502k
Total spending
£142k
Cost of raising funds
£5k
Reserves (reported)
£1.2m
Employees
2

Reported reserves equal ~101.3 months of spending — in the top quarter for charities its size (median 7.2 months; benchmarks).

Per its annual return, cost of raising funds: 1.0% of total income — below the median for charities its size (3.2%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2025£326k£284k
31/12/2024£502k£142k
31/12/2023£180k£223k
31/12/2022£382k£203k
31/12/2021£0£0

Common questions

Is THE CANCER TREATMENT AND RESEARCH TRUST CIO financially healthy?

Per its FY2025 accounts: The charity holds unrestricted free reserves of £1,221,038, which significantly exceed the trustees' stated policy target of covering two years of operating costs (£130,000). The trustees consider the charity to be a going concern, citing adequate resources to meet obligations for at least the next 12 months. Total income for the year was £325,771, with total expenditure at £283,831, resulting in a net surplus. Its FY2025 accounts were independently examined.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with CANCER CARE HOSPITAL & RESEARCH CHARITABLE TRUST.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
THE CANCER TREATMENT AND RESEARCH TRUST CIO£326k—0above—no doubt
CANCER CARE HOSPITAL & RESEARCH CHARITABLE TRUST FY2025£86k—0above—no doubt
COMBAT CANCER FY2025£50k—0above—no doubt
COST OF CANCER FY2024£24k—0above—no doubt
CANCER RELIEF UK FY2026£229k—0unclear—no doubt
CANCER CARE TRUST FY2025£48k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.